95 related articles for article (PubMed ID: 11025449)
1. Molecular characterization of celtix-1, a bromodomain protein interacting with the transcription factor interferon regulatory factor 2.
Staal A; Enserink JM; Stein JL; Stein GS; van Wijnen AJ
J Cell Physiol; 2000 Nov; 185(2):269-79. PubMed ID: 11025449
[TBL] [Abstract][Full Text] [Related]
2. HiNF-D (CDP-cut/CDC2/cyclin A/pRB-complex) influences the timing of IRF-2-dependent cell cycle activation of human histone H4 gene transcription at the G1/S phase transition.
Aziz F; van Wijnen AJ; Stein JL; Stein GS
J Cell Physiol; 1998 Dec; 177(3):453-64. PubMed ID: 9808153
[TBL] [Abstract][Full Text] [Related]
3. Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2.
Vaughan PS; Aziz F; van Wijnen AJ; Wu S; Harada H; Taniguchi T; Soprano KJ; Stein JL; Stein GS
Nature; 1995 Sep; 377(6547):362-5. PubMed ID: 7566094
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
5. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.
Peng C; Zhou J; Liu HY; Zhou M; Wang LL; Zhang QH; Yang YX; Xiong W; Shen SR; Li XL; Li GY
J Cell Biochem; 2006 Mar; 97(4):882-92. PubMed ID: 16265664
[TBL] [Abstract][Full Text] [Related]
6. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors.
Meraro D; Hashmueli S; Koren B; Azriel A; Oumard A; Kirchhoff S; Hauser H; Nagulapalli S; Atchison ML; Levi BZ
J Immunol; 1999 Dec; 163(12):6468-78. PubMed ID: 10586038
[TBL] [Abstract][Full Text] [Related]
7. Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation.
Nguyen H; Teskey L; Lin R; Hiscott J
Oncogene; 1999 Sep; 18(39):5455-63. PubMed ID: 10498899
[TBL] [Abstract][Full Text] [Related]
8. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression.
Tan RS; Taniguchi T; Harada H
Cancer Res; 1996 May; 56(10):2417-21. PubMed ID: 8625321
[TBL] [Abstract][Full Text] [Related]
9. Forced expression of the interferon regulatory factor 2 oncoprotein causes polyploidy and cell death in FDC-P1 myeloid hematopoietic progenitor cells.
Xie RL; van Wijnen AJ; van der Meijden CM; Stein JL; Stein GS
Cancer Res; 2002 May; 62(9):2510-5. PubMed ID: 11980642
[TBL] [Abstract][Full Text] [Related]
10. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain.
Yamamoto H; Lamphier MS; Fujita T; Taniguchi T; Harada H
Oncogene; 1994 May; 9(5):1423-8. PubMed ID: 8152803
[TBL] [Abstract][Full Text] [Related]
12. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of IRF3 and IRF7 in rainbow trout, Oncorhynchus mykiss: functional analysis and transcriptional modulation.
Holland JW; Bird S; Williamson B; Woudstra C; Mustafa A; Wang T; Zou J; Blaney SC; Collet B; Secombes CJ
Mol Immunol; 2008 Dec; 46(2):269-85. PubMed ID: 18805586
[TBL] [Abstract][Full Text] [Related]
14. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.
Xi H; Goodwin B; Shepherd AT; Blanck G
Oncogene; 2001 Jul; 20(31):4219-27. PubMed ID: 11464288
[TBL] [Abstract][Full Text] [Related]
15. PU.1/Interferon Regulatory Factor interactions: mechanisms of transcriptional regulation.
Marecki S; Fenton MJ
Cell Biochem Biophys; 2000; 33(2):127-48. PubMed ID: 11325034
[TBL] [Abstract][Full Text] [Related]
16. The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro.
Zhang S; Thomas K; Blanco JC; Salkowski CA; Vogel SN
J Endotoxin Res; 2002; 8(5):379-88. PubMed ID: 12537697
[TBL] [Abstract][Full Text] [Related]
17. Nucleolin is involved in interferon regulatory factor-2-dependent transcriptional activation.
Masumi A; Fukazawa H; Shimazu T; Yoshida M; Ozato K; Komuro K; Yamaguchi K
Oncogene; 2006 Aug; 25(37):5113-24. PubMed ID: 16582966
[TBL] [Abstract][Full Text] [Related]
18. Interferon regulatory factor-2 drives megakaryocytic differentiation.
Stellacci E; Testa U; Petrucci E; Benedetti E; Orsatti R; Feccia T; Stafsnes M; Coccia EM; Marziali G; Battistini A
Biochem J; 2004 Jan; 377(Pt 2):367-78. PubMed ID: 14505489
[TBL] [Abstract][Full Text] [Related]
19. Chromatin assembly factor 1 interacts with histone H3 methylated at lysine 79 in the processes of epigenetic silencing and DNA repair.
Zhou H; Madden BJ; Muddiman DC; Zhang Z
Biochemistry; 2006 Mar; 45(9):2852-61. PubMed ID: 16503640
[TBL] [Abstract][Full Text] [Related]
20. The integrated activities of IRF-2 (HiNF-M), CDP/cut (HiNF-D) and H4TF-2 (HiNF-P) regulate transcription of a cell cycle controlled human histone H4 gene: mechanistic differences between distinct H4 genes.
Aziz F; van Wijnen AJ; Vaughan PS; Wu S; Shakoori AR; Lian JB; Soprano KJ; Stein JL; Stein GS
Mol Biol Rep; 1998 Jan; 25(1):1-12. PubMed ID: 9540062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
